AV-1 / AbViro - LARVOL DELTA

AV1-PPD-0006: A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection (clinicaltrials.gov) - P2 | N=85 | Completed | Sponsor: AbViro LLC | Active, not recruiting ➔ Completed

Trial completion • Dengue Fever • Infectious Disease

AV1-PPD-0006: A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection (clinicaltrials.gov) - P2 | N=85 | Active, not recruiting | Sponsor: AbViro LLC | Recruiting ➔ Active, not recruiting

Enrollment closed • Dengue Fever • Infectious Disease

A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection (clinicaltrials.gov) - P2 | N=84 | Recruiting | Sponsor: AbViro LLC

New P2 trial • Dengue Fever • Infectious Disease

A Study to Determine the Safety of AV-1, an Antibody Being Developed for Treatment of Dengue, in Healthy Volunteers (clinicaltrials.gov) - P1a | N=42 | Completed | Sponsor: AbViro LLC | Recruiting ➔ Completed | Trial completion date: Oct 2020 ➔ Jul 2021 | Trial primary completion date: Oct 2020 ➔ Jul 2021

Trial completion • Trial completion date • Trial primary completion date • Dengue Fever